{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:54Z","timestamp":1789053174858,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T00:00:00Z","timestamp":1357776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s10067-012-2155-5","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T12:05:56Z","timestamp":1357733156000},"page":"673-678","source":"Crossref","is-referenced-by-count":15,"title":["Enteric-coated mycophenolate sodium for progressive systemic sclerosis\u2014a prospective open-label study with CT histography for monitoring of pulmonary fibrosis"],"prefix":"10.1007","volume":"32","author":[{"given":"Joerg C.","family":"Henes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Horger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Amberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fierlbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Koetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,10]]},"reference":[{"issue":"10","key":"2155_CR1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Air\u00f2 P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809\u201315","journal-title":"Ann Rheum Dis"},{"key":"2155_CR2","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE et al (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655\u201366","journal-title":"N Engl J Med"},{"key":"2155_CR3","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"RK Hoyles","year":"2006","unstructured":"Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS et al (2006) A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 54:3962\u20133970","journal-title":"Arthritis Rheum"},{"key":"2155_CR4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/rheumatology\/kep295","volume":"48","author":"CT Derk","year":"2009","unstructured":"Derk CT, Grace E, Shenin M, Naik M, Schulz S, Xiong W (2009) A prospective open label study of mycophenolate fort he treatment of diffuse systemic sclerosis. Rheumatology 48:1595\u201399","journal-title":"Rheumatology"},{"key":"2155_CR5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/rheumatology\/40.1.84","volume":"40","author":"RJ Stratton","year":"2001","unstructured":"Stratton RJ, Wilson H, Black CM (2001) Pilot study with antithymocyte globuline plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology 40:84\u201388","journal-title":"Rheumatology"},{"issue":"2","key":"2155_CR6","first-page":"287","volume":"25","author":"M Vanthuyne","year":"2007","unstructured":"Vanthuyne M, Blockmans D, Westhovens R, Roufosse F, Cogan E, Coche E et al (2007) A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis. Clin Exp Rheumatol 25(2):287\u201392","journal-title":"Clin Exp Rheumatol"},{"key":"2155_CR7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kei211","volume":"45","author":"SNC Liossis","year":"2006","unstructured":"Liossis SNC, Bounas A, Andonopoulos AP (2006) Mycophenolate mofetil as first line treatment improves clinically evident early scleroderma lung disease. Rheumatology 45:1005\u201308","journal-title":"Rheumatology"},{"key":"2155_CR8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/kel244","volume":"46","author":"SI Nihtyanova","year":"2007","unstructured":"Nihtyanova SI, Brough GM, Black CM, Denton CP (2007) Mycophenolate mofetil in diffuse cutaneous systemic sclerosis\u2014a retrospective analysis. Rheumatology 46:442\u2013445","journal-title":"Rheumatology"},{"issue":"6","key":"2155_CR9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/ard.2010.142000","volume":"70","author":"EN Le","year":"2011","unstructured":"Le EN, Wigley FM, Shah AA, Boin F, Hummers LK (2011) Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis. Ann Rheum Dis 70(6):1104\u20137","journal-title":"Ann Rheum Dis"},{"key":"2155_CR10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3899\/jrheum.111229","volume":"39","author":"FA Mendoza","year":"2012","unstructured":"Mendoza FA, Nagle SJ, Lee JB, Jimenez SA (2012) A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset. J Rheumatol 39:1241\u20137","journal-title":"J Rheumatol"},{"issue":"11","key":"2155_CR11","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10067-011-1823-1","volume":"30","author":"CP Sime\u00f3n-Aznar","year":"2011","unstructured":"Sime\u00f3n-Aznar CP, Fonollosa-Pl\u00e1 V, Tolosa-Vilella C, Selva-O'Callaghan A, Solans-Laqu\u00e9 R, Vilardell-Tarr\u00e9s M (2011) Effect of mycophenolate sodium in scleroderma-related interstitial lung disease. Clin Rheumatol 30(11):1393\u20138","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2155_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","volume":"4","author":"M Salvadori","year":"2004","unstructured":"Salvadori M, Holzer H, de Mattos A, Sollinger H, Arns W, Oppenheimer F et al (2004) Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 4(2):231\u20136","journal-title":"Am J Transplant"},{"issue":"6","key":"2155_CR13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/BOR.0b013e3283126985","volume":"20","author":"KM Antoniou","year":"2008","unstructured":"Antoniou KM, Wells AU (2008) Scleroderma lung disease: evolving understanding in light of newer studies. Curr Opin Rheumatol 20(6):686\u201391","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"2155_CR14","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s00330-009-1320-y","volume":"19","author":"E Cavigli","year":"2009","unstructured":"Cavigli E, Camiciottoli G, Diciotti S, Orlandi I, Spinelli C, Meoni E et al (2009) Whole lung densitometry versus visual assessment of emphysema. Eur Radiol 19(7):1686\u201392","journal-title":"Eur Radiol"},{"key":"2155_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1148\/rg.301095110","volume":"30","author":"S Matsuo","year":"2010","unstructured":"Matsuo S, Yamashiro T, Washko GR, Kurihara Y, Nakajima Y, Hatabu H (2010) Quantitative CT assessment of chronic obstructive pulmonary disease. Radiographics 30:55\u201366","journal-title":"Radiographics"},{"issue":"3","key":"2155_CR16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1378\/chest.06-1401","volume":"131","author":"G Camiciottoli","year":"2007","unstructured":"Camiciottoli G, Orlandi I, Bartolucci M, Meoni E, Nacci F, Diciotti S, Barcaroli C, Conforti ML, Pistolesi M, Matucci-Cerinic M, Mascalchi M (2007) Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 131(3):672\u201381","journal-title":"Chest"},{"issue":"5","key":"2155_CR17","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2534","volume":"10","author":"C Nannini","year":"2008","unstructured":"Nannini C, West CP, Erwin PJ, Matteson EL (2008) Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther 10(5):R124","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2155-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2155-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2155-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:57:23Z","timestamp":1559105843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2155-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,10]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2155"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2155-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,10]]}}}